AAAAAA
Results:
1-12
|
Results: 12
Authors:
Morrisett, JD
Insull, W
Citation: Jd. Morrisett et W. Insull, Evaluating atherosclerotic lesions by magnetic resonance imaging - From dimensional to compositional quantitation, ART THROM V, 21(10), 2001, pp. 1563-1564
Authors:
Insull, W
Kafonek, S
Goldner, D
Citation: W. Insull et al., Translated Paper: Comparison of efficacy and safety of atorvastatin (10 mg) and simvastatin (10 mg) at six weeks., PERFUSION, 14(6), 2001, pp. 244-250
Authors:
Isaacsohn, J
Insull, W
Stein, E
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, CA
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
Citation: J. Isaacsohn et al., Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia, CLIN CARD, 24(9), 2001, pp. 1-9
Authors:
Insull, W
Toth, P
Mullican, W
Hunninghake, D
Burke, S
Donovan, JM
Davidson, MH
Citation: W. Insull et al., Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial, MAYO CLIN P, 76(10), 2001, pp. 971-982
Authors:
Hunninghake, D
Insull, W
Toth, P
Davidson, D
Donovan, JM
Burke, SK
Citation: D. Hunninghake et al., Coadministration of colesevelam hydrochloride with atorvastatin lowers LDLcholesterol additively, ATHEROSCLER, 158(2), 2001, pp. 407-416
Authors:
Insull, W
Koren, M
Davignon, J
Sprecher, D
Schrott, H
Keilson, LM
Brown, AS
Dujovne, CA
Davidson, MH
McLain, R
Heinonen, T
Citation: W. Insull et al., Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia, ATHEROSCLER, 157(1), 2001, pp. 137-144
Authors:
Hunninghake, D
Insull, W
Knopp, R
Davidson, M
Lohrbauer, L
Jones, P
Kafonek, S
Citation: D. Hunninghake et al., Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia, AM J CARD, 88(6), 2001, pp. 635-639
Authors:
Insull, W
Kafonek, S
Goldner, D
Zieve, F
Citation: W. Insull et al., Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin(10 mg) at six weeks, AM J CARD, 87(5), 2001, pp. 554-559
Authors:
Davidson, MH
Stein, EA
Hunninghake, DB
Ose, L
Dujovne, CA
Insull, W
Bertolami, M
Weiss, SR
Kastelein, JJP
Scott, RS
Campodonico, S
Escobar, ID
Schrott, HG
Bays, H
Stepanavage, ME
Wu, M
Tate, AC
Melino, MR
Kush, D
Mercuri, M
Mitchel, YB
Citation: Mh. Davidson et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia, NUTR MET CA, 10(5), 2000, pp. 253-262
Authors:
Insull, W
Isaacsohn, J
Kwiterovich, P
Ma, P
Brazg, R
Dujovne, C
Shan, M
Shugrue-Crowley, E
Ripa, S
Tota, R
Citation: W. Insull et al., Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial, J INT MED R, 28(2), 2000, pp. 47-68
Authors:
Ose, L
Davidson, MH
Stein, EA
Kastelein, JJP
Scott, RS
Hunninghake, DB
Campodonico, S
Insull, W
Escobar, ID
Schrott, HG
Stepanavage, ME
Wu, M
Tate, AC
Melino, MR
Mercuri, M
Mitchel, YB
Citation: L. Ose et al., Lipid-altering efficacy and safety of simvastatin 80 mg/day: Long-term experience in a large group of patients with hypercholesterolemia, CLIN CARD, 23(1), 2000, pp. 39-46
Authors:
Knopp, RH
Superko, HR
Davidson, M
Insull, W
Dujovne, CA
Kwiterovich, PO
Zavoral, JH
Graham, K
O'Connor, RR
Edelman, DA
Citation: Rh. Knopp et al., Long-term blood cholesterol-lowering effects of a dietary fiber supplement, AM J PREV M, 17(1), 1999, pp. 18-23
Risultati:
1-12
|